Use to confirm the diagnosis of familial cerebral cavernous malformation in an individual with suggestive findings.
Massively Parallel Sequencing / Genomic Microarray (Oligo-based Array)
New York DOH Approval Status
Lavender (EDTA) or Yellow (ACD Solution A or B)
Transport 3 mL whole blood. (Min: 1.5 mL)
Serum or plasma; grossly hemolyzed or frozen specimens
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable
Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online.
Laboratory Developed Test (LDT)
Genes tested: CCM2, KRIT1, PDCD10
|Component Test Code*||Component Chart Name||LOINC|
|3002291||Cerebral Cavernous Malformation Specimen|
|3002292||Cerebral Cavernous Malformation Interp|
- familial CCL (FCCM)